Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 
First Trust NASDAQ-100 Equal Weighted Index Fund (QQEW)
Investment Objective/Strategy - The First Trust NASDAQ-100 Equal Weighted Index Fund is an exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the Nasdaq-100 Equal Weighted IndexSM.
There can be no assurance that the Fund's investment objectives will be achieved.
  • The Index consists of companies in the NASDAQ-100 Index.
  • The Index is reconstituted once a year in December, but replacements may be made during the year if there's a replacement in the NASDAQ-100 Index.
  • The Index is an equal weighted index and is rebalanced four times annually in March, June, September and December.
  • The Index contains the same securities as the NASDAQ-100 Index but each of the securities is initially set at a weight of 1.00% of the index and is rebalanced quarterly. The NASDAQ-100 Index includes 100 of the largest non-financial securities listed on Nasdaq.
  • The equal weighting allows for smaller company performance to contribute as much as the large companies within the Index.
Fund Overview
TickerQQEW
Fund TypeGrowth
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon Corp
CUSIP337344105
ISINUS3373441050
Intraday NAVQQEWIV
Fiscal Year-End12/31
ExchangeNasdaq
Inception4/19/2006
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.57%
Net Expense Ratio*0.57%
* As of 5/3/2021
Expenses are capped contractually at 0.60% per year, at least until April 30, 2023. Please see the Fees and Expenses of the Fund section in the fund’s prospectus for more details.
Current Fund Data (as of 5/20/2022)
Closing NAV1$89.68
Closing Market Price2$89.64
Bid/Ask Midpoint$89.68
Bid/Ask Discount0.01%
30-Day Median Bid/Ask Spread30.09%
Total Net Assets$995,409,825
Outstanding Shares11,100,002
Daily Volume57,988
Average 30-Day Daily Volume76,520
Closing Market Price 52-Week High/Low$120.98 / $87.97
Closing NAV 52-Week High/Low$120.94 / $88.02
Number of Holdings (excluding cash)102
Top Holdings (as of 5/20/2022)*
Holding Percent
Constellation Energy 1.34%
Exelon Corporation 1.27%
Monster Beverage Corporation 1.26%
Gilead Sciences, Inc. 1.25%
NetEase, Inc. (ADR) 1.25%
Xcel Energy Inc. 1.25%
American Electric Power Company, Inc. 1.23%
Amgen Inc. 1.22%
AstraZeneca Plc (ADR) 1.22%
Vertex Pharmaceuticals Incorporated 1.21%

* Excluding cash.  Holdings are subject to change.

NAV History (Since Inception)
Past performance is not indicative of future results.
Overall Morningstar RatingTM (as of 4/30/2022)4

Among 1,137 funds in the Large Growth category. This fund was rated 3 stars/1,137 funds (3 years), 3 stars/1,048 funds (5 years), 4 stars/775 funds (10 years) based on risk adjusted returns.
Distribution Information
Dividend per Share Amt (as of 5/22/2022)5$0.1831
30-Day SEC Yield (as of 4/29/2022)60.41%
Unsubsidized 30-Day SEC Yield (as of 4/29/2022)70.41%
12-Month Distribution Rate (as of 4/29/2022)80.40%
Index Yield (as of 4/29/2022)91.85%
Fund Characteristics (as of 4/29/2022)11
Maximum Market Cap.$2,551,594
Median Market Cap.$52,615
Minimum Market Cap.$15,012
Price/Earnings23.82
Price/Book4.76
Price/Cash Flow15.45
Price/Sales3.40
Bid/Ask Premium/Discount (as of 5/20/2022)